首页 > 最新文献

Turkish Journal of Internal Medicine最新文献

英文 中文
Turkish Nephrology on the 100th Anniversary of the Republic 共和国 100 周年之际的土耳其肾脏病学
Pub Date : 2024-01-10 DOI: 10.46310/tjim.1408413
Alparslan Ersoy
Nephrology specialization, obtained by completing a three-year subspecialty training after internal medicine specialization in Turkey, focuses mainly on diagnosing and treating kidney diseases. For thousands of years before the advent of the nephrology specialty, doctors struggled to diagnose kidney disorders. Nephrology is a term of Greek origin, nephros, meaning "kidney," combined with the suffix -logy, meaning "the study of." The word "kidney" appears for the first time in Turkish in the Orkhon inscriptions as "bögür," which indicates the name of the space between the rib bone and the hip. In the historical periods of Turkish, it is in the form of words meaning "kidney, bögür, böğür, bügür, bögr, yan." Later, in the Ottoman Period, the word “böğrek” was probably used in the sense of kidney by adding the suffix "-ek" to the word “böğür.” Although the term "böğür" is still widely used among the public to associate it with where the organ is located, it is now referred to as "kidney = böbrek". In the history of nephrology, diseases were first tried to be diagnosed and treated with clinical findings and urine analysis. In the 1940s, the basic principles of fluid-electrolyte physiology, homeostasis, the physiopathology of fluid-electrolyte disorders, renal functions, and dysfunctions began to be understood.
在土耳其,肾脏病学专业是在内科专业之后完成为期三年的亚专业培训而获得的,主要侧重于诊断和治疗肾脏疾病。在肾脏病学专业出现之前的数千年里,医生们一直在努力诊断肾脏疾病。肾脏病学一词源自希腊语,nephros意为 "肾脏",后缀-logy意为 "研究"。在土耳其语中,"肾脏 "一词首次出现在奥尔洪碑文中的 "bögür",表示肋骨和臀部之间的空隙。在土耳其语的历史时期,它以单词的形式出现,意思是 "肾、bögür、böğür、bügür、bögr、yan"。后来,在奥斯曼帝国时期,"böğrek "一词可能通过在 "böğür "后添加后缀"-ek "而被用于肾脏的含义。尽管 "böğür "一词在公众中仍被广泛使用,使人联想到器官所在的位置,但现在则被称为 "肾脏 = böbrek"。 在肾脏病学的历史上,人们最初试图通过临床发现和尿液分析来诊断和治疗疾病。20 世纪 40 年代,人们开始了解体液电解质生理学的基本原理、平衡、体液电解质紊乱的生理病理学、肾功能和功能障碍。
{"title":"Turkish Nephrology on the 100th Anniversary of the Republic","authors":"Alparslan Ersoy","doi":"10.46310/tjim.1408413","DOIUrl":"https://doi.org/10.46310/tjim.1408413","url":null,"abstract":"Nephrology specialization, obtained by completing a three-year subspecialty training after internal medicine specialization in Turkey, focuses mainly on diagnosing and treating kidney diseases. For thousands of years before the advent of the nephrology specialty, doctors struggled to diagnose kidney disorders. Nephrology is a term of Greek origin, nephros, meaning \"kidney,\" combined with the suffix -logy, meaning \"the study of.\" The word \"kidney\" appears for the first time in Turkish in the Orkhon inscriptions as \"bögür,\" which indicates the name of the space between the rib bone and the hip. In the historical periods of Turkish, it is in the form of words meaning \"kidney, bögür, böğür, bügür, bögr, yan.\" Later, in the Ottoman Period, the word “böğrek” was probably used in the sense of kidney by adding the suffix \"-ek\" to the word “böğür.” Although the term \"böğür\" is still widely used among the public to associate it with where the organ is located, it is now referred to as \"kidney = böbrek\". \u0000 In the history of nephrology, diseases were first tried to be diagnosed and treated with clinical findings and urine analysis. In the 1940s, the basic principles of fluid-electrolyte physiology, homeostasis, the physiopathology of fluid-electrolyte disorders, renal functions, and dysfunctions began to be understood.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"60 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139535116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Earthquake disaster impact on health care of cancer patients: Single center experience 地震灾害对癌症患者医疗保健的影响:单中心经验
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1327111
Oktay ÜNSAL, Ozan YAZICI, Nuriye YILDIRIM ÖZDEMİR, Gözde SAVAŞ, Ahmet ÖZET
Background: The earthquakes in February 2023 in Turkey had a major impact on Turkey's health system, causing damage to hospitals and health centres in the affected areas. Cancer patients are one of the groups that are highly influenced by the disaster. The aim of this study was to evaluate some of the demographic and clinical characteristics of cancer patients who are getting health care in earthquake-affected areas. Material and Methods: Fifty cancer patients who lived in 11 cities of Turkey affected by the earthquake and were admitted to Gazi University Department of Medical Oncology after the earthquake between 15 February 2023 and 15 March 2023 were included in the study. Data such as demographic characteristics, cancer diagnosis, time of cancer treatment, and earthquake history were taken retrospectively from nationally-linked electronic records (E-nabız). Results: Breast cancer was the most common diagnosis of these patients. Most of the patients were taking active treatment (60%). Chemotherapy and hormonotherapy were the most common treatment modalities (20% and 18%, respectively). The median delay in the active treatment of 14 cancer patients was 24 days (2-60). Conclusions: The earthquake disaster has led to important impacts on cancer patients' care in most affected areas. The human, financial and medical resources should be improved. Especially if detailed nationally-linked electronic records are provided, cancer patients will not have difficulty seeking health care. This disaster should be an important stimulus for hospitals and healthcare systems to improve the care of patients during disasters.
背景:2023年2月土耳其发生的地震对土耳其的卫生系统产生了重大影响,对受灾地区的医院和保健中心造成了破坏。癌症患者是受灾难影响最大的群体之一。本研究的目的是评估在地震灾区接受医疗保健的癌症患者的一些人口统计学和临床特征。材料与方法:研究纳入了居住在土耳其11个受地震影响城市的50名癌症患者,这些患者在2023年2月15日至2023年3月15日地震后被加齐大学肿瘤内科收治。人口统计学特征、癌症诊断、癌症治疗时间和地震史等数据回顾性地取自全国相关电子记录(E-nabız)。结果:乳腺癌是这些患者最常见的诊断。大多数患者都在积极治疗(60%)。化疗和激素治疗是最常见的治疗方式(分别占20%和18%)。14例癌症患者积极治疗的中位延迟时间为24天(2-60天)。结论:地震灾害对大部分受灾地区癌症患者的护理产生了重要影响。应改善人力、财力和医疗资源。特别是如果提供详细的全国联网电子记录,癌症患者寻求医疗保健将不会有困难。这场灾难应该成为医院和卫生保健系统改善灾害期间患者护理的重要刺激因素。
{"title":"Earthquake disaster impact on health care of cancer patients: Single center experience","authors":"Oktay ÜNSAL, Ozan YAZICI, Nuriye YILDIRIM ÖZDEMİR, Gözde SAVAŞ, Ahmet ÖZET","doi":"10.46310/tjim.1327111","DOIUrl":"https://doi.org/10.46310/tjim.1327111","url":null,"abstract":"Background: The earthquakes in February 2023 in Turkey had a major impact on Turkey's health system, causing damage to hospitals and health centres in the affected areas. Cancer patients are one of the groups that are highly influenced by the disaster. The aim of this study was to evaluate some of the demographic and clinical characteristics of cancer patients who are getting health care in earthquake-affected areas.
 Material and Methods: Fifty cancer patients who lived in 11 cities of Turkey affected by the earthquake and were admitted to Gazi University Department of Medical Oncology after the earthquake between 15 February 2023 and 15 March 2023 were included in the study. Data such as demographic characteristics, cancer diagnosis, time of cancer treatment, and earthquake history were taken retrospectively from nationally-linked electronic records (E-nabız).
 Results: Breast cancer was the most common diagnosis of these patients. Most of the patients were taking active treatment (60%). Chemotherapy and hormonotherapy were the most common treatment modalities (20% and 18%, respectively). The median delay in the active treatment of 14 cancer patients was 24 days (2-60).
 Conclusions: The earthquake disaster has led to important impacts on cancer patients' care in most affected areas. The human, financial and medical resources should be improved. Especially if detailed nationally-linked electronic records are provided, cancer patients will not have difficulty seeking health care. This disaster should be an important stimulus for hospitals and healthcare systems to improve the care of patients during disasters.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"65 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Frequency of Musculoskeletal Pain in Nurses Working in Internal Medicine Intensive Care Unit and Related Factors 内科重症监护室护士肌肉骨骼疼痛发生率及相关因素分析
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1345172
Aytül COŞAR ERTEM, Uğur ERTEM
Background: The primary purpose of this study was to determine the frequency of musculoskeletal pain in nurses working in the internal medicine intensive care unit and to determine whether there were differences between nurses working in the internal medicine clinic. In addition, it was aimed to determine the individual and professional risk factors that will cause musculoskeletal pain in nurses working in the internal medicine intensive care unit. Material and Methods: After evaluating eligibility, 82 volunteer nurses, 36 working in the internal medicine intensive care unit and 46 working in the internal medicine clinic, were included in this single-centre, cross-sectional and descriptive study. The demographic characteristics of the participants, their regular exercise status and the factors related to their working conditions were determined by the questionnaire form created by the researchers. Results: Musculoskeletal pain was detected in 61.11% of internal medicine intensive care nurses. There was no statistical difference between the internal medicine intensive care and clinical nurses regarding musculoskeletal pain (p>0.05). A statistically significant relationship was found between the situation of changing the patient's clothes and positioning the patient and the occurrence of musculoskeletal pain (p
背景:本研究的主要目的是确定在内科重症监护室工作的护士发生肌肉骨骼疼痛的频率,并确定在内科门诊工作的护士之间是否存在差异。此外,它的目的是确定个人和专业的危险因素,将导致肌肉骨骼疼痛的护士在内科重症监护室工作。 材料和方法:在评估合格性后,82名志愿护士,36名在内科重症监护病房工作,46名在内科诊所工作,被纳入这项单中心、横断面和描述性研究。参与者的人口学特征、他们的定期运动状况以及与他们的工作条件相关的因素通过研究人员制作的问卷形式确定。 结果:61.11%的内科重症护士存在肌肉骨骼疼痛。内科重症监护护士与临床护士在肌肉骨骼疼痛方面差异无统计学意义(p>0.05)。患者换衣服和体位的情况与肌肉骨骼疼痛的发生之间存在统计学上显著的关系(p
{"title":"The Frequency of Musculoskeletal Pain in Nurses Working in Internal Medicine Intensive Care Unit and Related Factors","authors":"Aytül COŞAR ERTEM, Uğur ERTEM","doi":"10.46310/tjim.1345172","DOIUrl":"https://doi.org/10.46310/tjim.1345172","url":null,"abstract":"Background: The primary purpose of this study was to determine the frequency of musculoskeletal pain in nurses working in the internal medicine intensive care unit and to determine whether there were differences between nurses working in the internal medicine clinic. In addition, it was aimed to determine the individual and professional risk factors that will cause musculoskeletal pain in nurses working in the internal medicine intensive care unit.
 Material and Methods: After evaluating eligibility, 82 volunteer nurses, 36 working in the internal medicine intensive care unit and 46 working in the internal medicine clinic, were included in this single-centre, cross-sectional and descriptive study. The demographic characteristics of the participants, their regular exercise status and the factors related to their working conditions were determined by the questionnaire form created by the researchers.
 Results: Musculoskeletal pain was detected in 61.11% of internal medicine intensive care nurses. There was no statistical difference between the internal medicine intensive care and clinical nurses regarding musculoskeletal pain (p>0.05). A statistically significant relationship was found between the situation of changing the patient's clothes and positioning the patient and the occurrence of musculoskeletal pain (p","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"65 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Unusual Cause of Bilateral Adrenal Incidentaloma: A Case Report of Primary Adrenal Lymphoma 双侧肾上腺偶发瘤的一个不寻常原因:原发性肾上腺淋巴瘤1例报告
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1348432
Mert TOKATLI, Neslihan Nisa GECİCİ, Meral Ilgaz ERGİN, Umit Yavuz MALKAN, Oguz Abdullah UYAROGLU
Primary adrenal lymphoma (PAL) is an extremely rare among the causes of adrenal incidentaloma. Most were diagnosed with adrenal insufficiency and B symptoms (unexplained weight loss, night sweats, fever). This article presented a 57-year-old woman who was investigated for bilateral adrenal masses found incidentally on computed tomography (CT). Physical examination and laboratory tests revealed no evidence of adrenal insufficiency or B symptoms. Only 24-hour urinary metanephrine and normetanephrine excretion were increased. Tumour F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET/CT) scan showed the greatest dimension was 14 cm in the left adrenal mass and the maximum standardized uptake value (SUV max) was 26.1 (relative to mean SUV in the normal liver parenchyma, which was 2). An adrenal biopsy was performed after taking adequate precautions against the possibility of a catecholamine crisis. Histopathology revealed high-grade B-cell lymphoma. Bone marrow involvement and brain metastasis were not observed. She received the R-EPOCH (rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) regimen and intrathecal methotrexate therapy as central nervous system prophylaxis. The patient responded well to treatment, and close clinical follow-up continues. PAL should always be considered when a bilateral adrenal mass is detected.
原发性肾上腺淋巴瘤(PAL)是一种极为罕见的肾上腺偶发瘤。大多数被诊断为肾上腺功能不全和B症状(不明原因的体重减轻、盗汗、发烧)。本文报告一位57岁的女性,在CT上偶然发现双侧肾上腺肿块。体格检查和实验室检查均未发现肾上腺功能不全或B型症状。仅24小时尿中肾上腺素和去甲肾上腺素排泄量增加。肿瘤F-18氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET/CT)显示左侧肾上腺肿块最大尺寸为14 cm,最大标准化摄取值(SUV max)为26.1(相对于正常肝实质的平均SUV为2)。在采取充分预防儿茶酚胺危机的可能性后,进行了肾上腺活检。组织病理学显示为高级别b细胞淋巴瘤。未见骨髓受累及脑转移。她接受R-EPOCH(利妥昔单抗、依托泊苷、强的松、长春新碱、环磷酰胺和阿霉素)方案和鞘内甲氨蝶呤治疗作为中枢神经系统预防。患者对治疗反应良好,继续密切临床随访。当检测到双侧肾上腺肿块时,应考虑PAL。
{"title":"An Unusual Cause of Bilateral Adrenal Incidentaloma: A Case Report of Primary Adrenal Lymphoma","authors":"Mert TOKATLI, Neslihan Nisa GECİCİ, Meral Ilgaz ERGİN, Umit Yavuz MALKAN, Oguz Abdullah UYAROGLU","doi":"10.46310/tjim.1348432","DOIUrl":"https://doi.org/10.46310/tjim.1348432","url":null,"abstract":"Primary adrenal lymphoma (PAL) is an extremely rare among the causes of adrenal incidentaloma. Most were diagnosed with adrenal insufficiency and B symptoms (unexplained weight loss, night sweats, fever). This article presented a 57-year-old woman who was investigated for bilateral adrenal masses found incidentally on computed tomography (CT). Physical examination and laboratory tests revealed no evidence of adrenal insufficiency or B symptoms. Only 24-hour urinary metanephrine and normetanephrine excretion were increased. Tumour F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET/CT) scan showed the greatest dimension was 14 cm in the left adrenal mass and the maximum standardized uptake value (SUV max) was 26.1 (relative to mean SUV in the normal liver parenchyma, which was 2). An adrenal biopsy was performed after taking adequate precautions against the possibility of a catecholamine crisis. Histopathology revealed high-grade B-cell lymphoma. Bone marrow involvement and brain metastasis were not observed. She received the R-EPOCH (rituximab, etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) regimen and intrathecal methotrexate therapy as central nervous system prophylaxis. The patient responded well to treatment, and close clinical follow-up continues. PAL should always be considered when a bilateral adrenal mass is detected.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Evaluation of Patients Who Underwent Allogeneic Stem Cell Transplantation for Bone Marrow Failure 接受同种异体干细胞移植治疗骨髓衰竭患者的回顾性评价
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1359793
Tuba ERSAL, Vildan OZKOCAMAN
Background: Bone marrow failure is a disease that develops due to different etiologies. Aplastic anaemia (AA) and hypocellular myelodysplastic syndrome (HMDS) are the most common bone marrow failure disorders. Treatment options include supportive therapy, immunosuppressive therapy, and allogeneic hematopoietic stem cell transplantation (allo-HCT). Allo-HCT is the only curative treatment option. This study aimed to retrospectively evaluate the demographic characteristics, treatment, and transplantation results of patients who underwent Allo-HCT for bone marrow failure. Material and Methods: This single-centre retrospective study enrolled 11 patients (9 with severe AA and 2 with HMDS) who underwent allo-HCT for bone marrow failure. The patients' records until 17.08.2023 were analysed. Age, gender, diagnosis, donor age and gender, type of transplantation, pre-transplant ferritin levels, time to transplantation, volume of infused product, number of CD34+ cells in the infused product, post-transplant engraftment times, discharge time, transplant-related complications, post-transplant follow-up and overall survival times were obtained. Results: Eleven patients underwent 12 allo-HCTs for bone marrow failure. Seven patients were male, and four were female. The median age was 40, and seven patients were ≥40 years old at the time of transplantation. Eleven transplants were performed from HLA fully matched siblings and one from a 9/10 matched sibling donor. Bone marrow was used as a stem cell source in 8 transplants and peripheral blood in 4 transplants. The conditioning regimen was fludarabine/cyclophosphamide/anti-thymocyte globulin in all patients. The median time from diagnosis to transplantation was five months. The median time for neutrophil engraftment was 23 days. The median platelet >20.000/mm3 engraftment time was 16 days. A statistically significant positive correlation was found between ferritin levels and platelet >20.000/mm3 engraftment (days) (r=0.653, p=0.040) and platelet >50.000/mm3 engraftment (days) (r=0.720, p=0.029). There was a statistically significant negative correlation between the number of infused CD34 positive cells (10⁶/kg) and platelet >50.000/mm3 engraftment (days) (r=-0.670, p=0.024). Patients were discharged in a median of 23 days. Acute graft versus host disease (GvHD) was observed in one patient, while chronic GvHD was not observed in any patient. The median overall survival time was 48 months, and the median post-transplant follow-up was 37 months. Secondary malignancy and MDS were not detected in any patient during the follow-up period. All 11 patients who underwent Allo-HCT from a matched sibling donor are alive and continue to have a complete hematological response. There was no increase in mortality and morbidity in patients aged 40 years and older. Conclusions: In patients with severe AA and high-risk HMDS without comorbidities between the ages of 40 and 50, allo-HCT should be consider
背景:骨髓衰竭是一种由不同病因引起的疾病。再生障碍性贫血(AA)和低细胞骨髓增生异常综合征(HMDS)是最常见的骨髓衰竭疾病。治疗方案包括支持疗法、免疫抑制疗法和同种异体造血干细胞移植(alloo - hct)。Allo-HCT是唯一的治疗选择。本研究旨在回顾性评估因骨髓衰竭而接受同种异体hct治疗的患者的人口学特征、治疗和移植结果。材料和方法:这项单中心回顾性研究纳入了11例因骨髓衰竭接受同种异体hct治疗的患者(9例重度AA, 2例HMDS)。分析截至2023年8月17日的患者记录。获取年龄、性别、诊断、供体年龄及性别、移植类型、移植前铁蛋白水平、移植时间、输注产物体积、输注产物中CD34+细胞数、移植后植入次数、出院时间、移植相关并发症、移植后随访及总生存时间。 结果:11例患者因骨髓衰竭接受了12次同种异体移植。男性7例,女性4例。中位年龄为40岁,7例患者移植时年龄≥40岁。11例移植来自HLA完全匹配的兄弟姐妹,1例来自9/10匹配的兄弟姐妹供体。8例移植以骨髓作为干细胞来源,4例移植以外周血作为干细胞来源。所有患者的调理方案均为氟达拉滨/环磷酰胺/抗胸腺细胞球蛋白。从诊断到移植的中位时间为5个月。中性粒细胞移植的中位时间为23天。血小板20.000/mm3的中位植入时间为16天。铁蛋白水平与血小板20.000/mm3 (d) (r=0.653, p=0.040)、血小板50.000/mm3 (d) (r=0.720, p=0.029)呈显著正相关。输注CD34阳性细胞数(10 26 /kg)与血小板(5万/mm3)(天)呈显著负相关(r=-0.670, p=0.024)。患者出院的平均时间为23天。在1例患者中观察到急性移植物抗宿主病(GvHD),而在任何患者中未观察到慢性移植物抗宿主病。中位总生存时间为48个月,中位移植后随访时间为37个月。随访期间未发现继发性恶性肿瘤和MDS。11例接受同种异体造血干细胞移植的患者均存活,血液学反应完全。40岁及以上患者的死亡率和发病率没有增加。 结论:对于年龄在40 - 50岁之间无合合症的重度AA和高危HMDS患者,在存在hla匹配的兄弟姐妹供体的情况下,应考虑采用同种异体hct作为一线治疗。
{"title":"Retrospective Evaluation of Patients Who Underwent Allogeneic Stem Cell Transplantation for Bone Marrow Failure","authors":"Tuba ERSAL, Vildan OZKOCAMAN","doi":"10.46310/tjim.1359793","DOIUrl":"https://doi.org/10.46310/tjim.1359793","url":null,"abstract":"Background: Bone marrow failure is a disease that develops due to different etiologies. Aplastic anaemia (AA) and hypocellular myelodysplastic syndrome (HMDS) are the most common bone marrow failure disorders. Treatment options include supportive therapy, immunosuppressive therapy, and allogeneic hematopoietic stem cell transplantation (allo-HCT). Allo-HCT is the only curative treatment option. This study aimed to retrospectively evaluate the demographic characteristics, treatment, and transplantation results of patients who underwent Allo-HCT for bone marrow failure.
 Material and Methods: This single-centre retrospective study enrolled 11 patients (9 with severe AA and 2 with HMDS) who underwent allo-HCT for bone marrow failure. The patients' records until 17.08.2023 were analysed. Age, gender, diagnosis, donor age and gender, type of transplantation, pre-transplant ferritin levels, time to transplantation, volume of infused product, number of CD34+ cells in the infused product, post-transplant engraftment times, discharge time, transplant-related complications, post-transplant follow-up and overall survival times were obtained.
 Results: Eleven patients underwent 12 allo-HCTs for bone marrow failure. Seven patients were male, and four were female. The median age was 40, and seven patients were ≥40 years old at the time of transplantation. Eleven transplants were performed from HLA fully matched siblings and one from a 9/10 matched sibling donor. Bone marrow was used as a stem cell source in 8 transplants and peripheral blood in 4 transplants. The conditioning regimen was fludarabine/cyclophosphamide/anti-thymocyte globulin in all patients. The median time from diagnosis to transplantation was five months. The median time for neutrophil engraftment was 23 days. The median platelet >20.000/mm3 engraftment time was 16 days. A statistically significant positive correlation was found between ferritin levels and platelet >20.000/mm3 engraftment (days) (r=0.653, p=0.040) and platelet >50.000/mm3 engraftment (days) (r=0.720, p=0.029). There was a statistically significant negative correlation between the number of infused CD34 positive cells (10⁶/kg) and platelet >50.000/mm3 engraftment (days) (r=-0.670, p=0.024). Patients were discharged in a median of 23 days. Acute graft versus host disease (GvHD) was observed in one patient, while chronic GvHD was not observed in any patient. The median overall survival time was 48 months, and the median post-transplant follow-up was 37 months. Secondary malignancy and MDS were not detected in any patient during the follow-up period. All 11 patients who underwent Allo-HCT from a matched sibling donor are alive and continue to have a complete hematological response. There was no increase in mortality and morbidity in patients aged 40 years and older.
 Conclusions: In patients with severe AA and high-risk HMDS without comorbidities between the ages of 40 and 50, allo-HCT should be consider","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Do Donor-Specific Antibody Changes Mean in Kidney Transplant Patients? 肾移植患者供体特异性抗体变化意味着什么?
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1249847
Talat AYKUT, Hakan OZER, İsmail BALOĞLU, Fatih SAÇKAN, Kültigin TÜRKMEN
Objective: The role of immunological evaluation is significant in selecting a suitable donor to reduce post-transplant complications in kidney transplantation (KTx). It is unknown how often donor-specific antibody (DSA) positivity causes rejection or how often rejection will develop in patients who do not develop DSA positivity. We aimed to evaluate the relationship between the DSA changes and the KTx patients' biochemical parameters. Methods: The study was a cross-sectional study evaluating 45 KTx patients. Demographic and clinical characteristics of the patients, pre-transplant DSA values, post-transplant DSA values, and biochemical parameters were retrospectively scanned from the hospital system. The patients' data were divided into three groups according to DSA changes. Results: DSA was negative in 21 (46%) patients and positive in 24 (54%) before transplantation. In the post-transplant follow-up, it was observed that the DSA value became positive in 7 patients and turned negative in 9 patients. Rejection developed in 22% of 9 patients whose DSA was positive before transplantation and turned negative after transplantation, and in 28% of 7 patients turned positive from negative. Estimated glomerular filtration rate (e-GFR) and creatinine levels in the post-transplant period were associated with the change in DSA. Also, e-GFR and neutrophil values were independently associated with rejection. Conclusions: Although DSA change affects kidney functions, we found that DSA positivity alone cannot predict rejection, and rejection may occur in the DSA-negative group. Neutrophil count and e-GFR changes were closely related to rejection. Therefore, DSA levels should be monitored regularly, but DSA change alone is insufficient for rejection evaluation.
目的:免疫评价在肾移植中选择合适的供体以减少移植后并发症方面具有重要意义。目前尚不清楚供体特异性抗体(DSA)阳性引起排斥反应的频率,也不清楚没有DSA阳性的患者发生排斥反应的频率。我们的目的是评估DSA变化与KTx患者生化参数的关系。 方法:本研究为横断面研究,评估45例KTx患者。从医院系统中回顾性扫描患者的人口学和临床特征、移植前DSA值、移植后DSA值和生化参数。根据DSA变化将患者数据分为三组。 结果:移植前DSA阴性21例(46%),阳性24例(54%)。在移植后随访中,观察到7例患者DSA值转为阳性,9例患者DSA值转为阴性。9例DSA在移植前呈阳性,移植后转为阴性的患者中有22%发生排斥反应,7例由阴性转为阳性的患者中有28%发生排斥反应。移植后估计的肾小球滤过率(e-GFR)和肌酐水平与DSA的变化有关。此外,e-GFR和中性粒细胞值与排斥反应独立相关。 结论:虽然DSA改变会影响肾功能,但我们发现仅DSA阳性不能预测排斥反应,DSA阴性组可能发生排斥反应。中性粒细胞计数和e-GFR变化与排斥反应密切相关。因此,应定期监测DSA水平,但仅DSA变化不足以评估排斥反应。
{"title":"What Do Donor-Specific Antibody Changes Mean in Kidney Transplant Patients?","authors":"Talat AYKUT, Hakan OZER, İsmail BALOĞLU, Fatih SAÇKAN, Kültigin TÜRKMEN","doi":"10.46310/tjim.1249847","DOIUrl":"https://doi.org/10.46310/tjim.1249847","url":null,"abstract":"Objective: The role of immunological evaluation is significant in selecting a suitable donor to reduce post-transplant complications in kidney transplantation (KTx). It is unknown how often donor-specific antibody (DSA) positivity causes rejection or how often rejection will develop in patients who do not develop DSA positivity. We aimed to evaluate the relationship between the DSA changes and the KTx patients' biochemical parameters.
 Methods: The study was a cross-sectional study evaluating 45 KTx patients. Demographic and clinical characteristics of the patients, pre-transplant DSA values, post-transplant DSA values, and biochemical parameters were retrospectively scanned from the hospital system. The patients' data were divided into three groups according to DSA changes.
 Results: DSA was negative in 21 (46%) patients and positive in 24 (54%) before transplantation. In the post-transplant follow-up, it was observed that the DSA value became positive in 7 patients and turned negative in 9 patients. Rejection developed in 22% of 9 patients whose DSA was positive before transplantation and turned negative after transplantation, and in 28% of 7 patients turned positive from negative. Estimated glomerular filtration rate (e-GFR) and creatinine levels in the post-transplant period were associated with the change in DSA. Also, e-GFR and neutrophil values were independently associated with rejection.
 Conclusions: Although DSA change affects kidney functions, we found that DSA positivity alone cannot predict rejection, and rejection may occur in the DSA-negative group. Neutrophil count and e-GFR changes were closely related to rejection. Therefore, DSA levels should be monitored regularly, but DSA change alone is insufficient for rejection evaluation.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"5 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maternal and fetal outcomes in pregnant women with Takayasu’s arteritis: single center experience over ten years 妊娠女性高松动脉炎的母胎结局:10年以上的单中心经验
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1290999
Burcu YAĞIZ, Belkıs Nihan COŞKUN, Orkun SAKAR, Hüseyin Ediz DALKILIÇ, Yavuz PEHLİVAN
Background: This study aims to assess pregnant women's maternal and fetal outcomes with Takayasu’s arteritis (TA). Material and Methods: The study comprised ten pregnant women at the time of diagnosis or afterwards among the 50 patients diagnosed with TA between 2003 and 2021. Twenty-one pregnancy outcomes of 10 patients were obtained from hospital records and telephonic interviews. Two pregnancies were excluded due to timing before diagnosis. Results: Based on the angiographic classification, six patients had type 1, two had type 2b, and two had type 1+4 TA. 63.15% of pregnancies were planned, and the rheumatologist approved 42.10%. Live birth occurred in 16 (84.2%) of 19 pregnancies, three pregnancies (15.7%) resulted in abortion and two (10.5 %) of 19 pregnancies ended in neonatal death. In five (26.3%) of the 19 pregnancies, the disease was activated during pregnancy. Two neonatal deaths were from the two patients diagnosed with preeclampsia during pregnancy. Pre-existing hypertension and active disease are shared features of these two patients. After one year of follow-up, six pregnancies (31.5%) had active disease, and four (66.6%) had active disease both before and during pregnancy. While fetal data analysis revealed no congenital anomalies, four pregnancies resulted in low birth weight and intrauterine growth retardation (21.05%). Conclusions: The risk of developing preeclampsia and neonatal death should be considered, especially in TA patients with pre-existing hypertension who become pregnant during active disease.
背景:本研究旨在评估孕妇患高松动脉炎(Takayasu’s arteritis, TA)的母婴结局。材料和方法:该研究包括2003年至2021年期间诊断为TA的50名患者中诊断时或之后的10名孕妇。通过医院记录和电话访谈获取10例患者的21例妊娠结局。由于诊断前的时机,排除了两次妊娠。 结果:根据血管造影分类,1型6例,2b型2例,1+4型2例。63.15%的妊娠是计划妊娠,而风湿病专家认可的比例为42.10%。19例妊娠中有16例(84.2%)为活产,3例(15.7%)为流产,19例妊娠中有2例(10.5%)为新生儿死亡。在19例妊娠中,有5例(26.3%)在妊娠期间发病。两名新生儿死亡来自于两名在怀孕期间被诊断为子痫前期的患者。既往高血压和活动性疾病是这两例患者的共同特征。经过一年的随访,6名孕妇(31.5%)有活动性疾病,4名孕妇(66.6%)在怀孕前和怀孕期间都有活动性疾病。虽然胎儿数据分析显示没有先天性异常,但有4例妊娠导致出生体重过低和宫内生长迟缓(21.05%)。结论:应考虑发生先兆子痫和新生儿死亡的风险,特别是对于在活动性疾病期间怀孕的已有高血压的TA患者。
{"title":"Maternal and fetal outcomes in pregnant women with Takayasu’s arteritis: single center experience over ten years","authors":"Burcu YAĞIZ, Belkıs Nihan COŞKUN, Orkun SAKAR, Hüseyin Ediz DALKILIÇ, Yavuz PEHLİVAN","doi":"10.46310/tjim.1290999","DOIUrl":"https://doi.org/10.46310/tjim.1290999","url":null,"abstract":"Background: This study aims to assess pregnant women's maternal and fetal outcomes with Takayasu’s arteritis (TA).
 Material and Methods: The study comprised ten pregnant women at the time of diagnosis or afterwards among the 50 patients diagnosed with TA between 2003 and 2021. Twenty-one pregnancy outcomes of 10 patients were obtained from hospital records and telephonic interviews. Two pregnancies were excluded due to timing before diagnosis.
 Results: Based on the angiographic classification, six patients had type 1, two had type 2b, and two had type 1+4 TA. 63.15% of pregnancies were planned, and the rheumatologist approved 42.10%. Live birth occurred in 16 (84.2%) of 19 pregnancies, three pregnancies (15.7%) resulted in abortion and two (10.5 %) of 19 pregnancies ended in neonatal death. In five (26.3%) of the 19 pregnancies, the disease was activated during pregnancy. Two neonatal deaths were from the two patients diagnosed with preeclampsia during pregnancy. Pre-existing hypertension and active disease are shared features of these two patients. After one year of follow-up, six pregnancies (31.5%) had active disease, and four (66.6%) had active disease both before and during pregnancy. While fetal data analysis revealed no congenital anomalies, four pregnancies resulted in low birth weight and intrauterine growth retardation (21.05%).
 Conclusions: The risk of developing preeclampsia and neonatal death should be considered, especially in TA patients with pre-existing hypertension who become pregnant during active disease.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"54 2","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenal Cystic Lymphangioma with Radiological, Clinical and Histopathological Findings, Case report. 肾上腺囊性淋巴管瘤的影像学、临床及病理表现,1例报告。
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1336374
Kağan GÖKÇE, Aşkın Sena AKÇAY, Demet DOĞAN, Ahmet MİDİ, Ayşe Nimet KARADAYI
Cystic lymphangiomas are benign lesions originating from lymphatic endothelial cells. It occurs due to developmental anomalies of lymphatic vessels. They are usually localized in the head and neck region. Cystic lymphangiomas of adrenal origin are very rare. This presentation aims to report a case of left-sided adrenal cystic lymphangioma detected incidentally on radiological examination due to abdominal pain, with clinical, radiological, and pathological findings. A 65-year-old female patient was admitted to our clinic with abdominal pain. In the abdominal examination, the pain was detected in the epigastric region and left the upper quadrant with palpation. No pathology was observed in the complete blood count and biochemical parameters, except for a CRP elevation of 10.2 mg/dL. In examination with ultrasonography (US), in the left upper quadrant of the abdomen, in the localization of the adrenal gland, a multilocular cystic lesion with partially dense contents, which is not vascularised by Doppler US, containing thin echogenic septa was detected. Enhanced contrast multidetector computed tomography was performed to determine the nature and characterization of the mass. A 60x57 mm cystic lesion with multi-lobulated contour and fluid density was defined in the left adrenal gland. The patient was diagnosed with cystic lymphangioma radiologically and was operated upon due to symptoms and size. Pathological diagnosis was reported as cystic lymphangioma. Preoperative clinical and radiological correct diagnosis is critical because the treatment approach and prognosis may differ from other adrenal tumors or cysts.
囊性淋巴管瘤是起源于淋巴内皮细胞的良性病变。它是由淋巴管发育异常引起的。它们通常局限于头颈部。起源于肾上腺的囊性淋巴管瘤是非常罕见的。本报告报告一例左侧肾上腺囊性淋巴管瘤,因腹痛而在放射检查中偶然发现,并有临床、放射和病理表现。一名65岁女性患者因腹痛入院。腹部检查时,痛见于上腹部,触诊左侧上腹。除CRP升高10.2 mg/dL外,全血细胞计数和生化参数均未见病理变化。在超声检查中,在腹部左上象限的肾上腺定位处,发现一多室囊性病变,部分致密内容物,多普勒超声检查未见血管,含薄回声间隔。进行增强对比多检测器计算机断层扫描以确定肿块的性质和特征。左侧肾上腺可见60x57 mm囊性病变,呈多分叶状轮廓和液体密度。患者经放射学诊断为囊性淋巴管瘤,并因症状及大小接受手术治疗。病理诊断为囊性淋巴管瘤。由于治疗方法和预后可能不同于其他肾上腺肿瘤或囊肿,因此术前临床和影像学的正确诊断至关重要。
{"title":"Adrenal Cystic Lymphangioma with Radiological, Clinical and Histopathological Findings, Case report.","authors":"Kağan GÖKÇE, Aşkın Sena AKÇAY, Demet DOĞAN, Ahmet MİDİ, Ayşe Nimet KARADAYI","doi":"10.46310/tjim.1336374","DOIUrl":"https://doi.org/10.46310/tjim.1336374","url":null,"abstract":"Cystic lymphangiomas are benign lesions originating from lymphatic endothelial cells. It occurs due to developmental anomalies of lymphatic vessels. They are usually localized in the head and neck region. Cystic lymphangiomas of adrenal origin are very rare. This presentation aims to report a case of left-sided adrenal cystic lymphangioma detected incidentally on radiological examination due to abdominal pain, with clinical, radiological, and pathological findings. A 65-year-old female patient was admitted to our clinic with abdominal pain. In the abdominal examination, the pain was detected in the epigastric region and left the upper quadrant with palpation. No pathology was observed in the complete blood count and biochemical parameters, except for a CRP elevation of 10.2 mg/dL. In examination with ultrasonography (US), in the left upper quadrant of the abdomen, in the localization of the adrenal gland, a multilocular cystic lesion with partially dense contents, which is not vascularised by Doppler US, containing thin echogenic septa was detected. Enhanced contrast multidetector computed tomography was performed to determine the nature and characterization of the mass. A 60x57 mm cystic lesion with multi-lobulated contour and fluid density was defined in the left adrenal gland. The patient was diagnosed with cystic lymphangioma radiologically and was operated upon due to symptoms and size. Pathological diagnosis was reported as cystic lymphangioma. Preoperative clinical and radiological correct diagnosis is critical because the treatment approach and prognosis may differ from other adrenal tumors or cysts.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"74 6","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An underestimated old friend: Serum protein electrophoresis in the differential diagnosis of glomerulopathies 被低估的老朋友:血清蛋白电泳在肾小球疾病鉴别诊断中的应用
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1358169
Ahmet Bilgehan ŞAHİN, Safiye BAKKAL, Saide GÜLLÜLÜ, Ayşegül ORUÇ, Abdülmecit YILDIZ, Mehmet Fethullah AYDIN, Alparslan ERSOY, Gökhan OCAKOĞLU, Mustafa GÜLLÜLÜ
Background: Serum protein electrophoresis (SPEP) is an easy test separating serum proteins based on their physical and chemical properties. Although it is frequently used in the differential diagnosis of multiple myeloma and various chronic inflammatory diseases, its value in the etiologic classification of glomerular diseases has yet to be studied. Material and Methods: We retrospectively reviewed the medical records of patients who underwent renal biopsy from 2008 to 2016 at our institution. We excluded patients who can not be classified as primary (PGn) or secondary glomerulonephritis (SGn). Univariate and multivariate logistic regression analyses were performed for the prediction of SGn. Results: Four hundred thirty-two patients were included in the study. Of those, 57.9% had PGn. Rheumatological diseases, malignancies, and infections were the most common etiologic causes of SGn, accounting for nearly 75%. Univariate analysis revealed that alpha-1 (α1), gamma (Ɣ), and albumin fractions significantly differ between PGn and SGn groups. ROC curve analysis determined the cut-off value of (α1*Ɣ)/albumin ratio as 1.48. Multivariate analysis revealed that total serum protein and (α1*Ɣ)/albumin ratio were significantly independent predictors for SGn (p=0.020 and p
背景:血清蛋白电泳(SPEP)是一种根据理化性质分离血清蛋白的简便方法。虽然常用于多发性骨髓瘤和各种慢性炎性疾病的鉴别诊断,但其在肾小球疾病病因学分类中的价值尚未研究。 材料和方法:我们回顾性地回顾了2008年至2016年在我院接受肾活检的患者的病历。我们排除了不能归类为原发性(PGn)或继发性肾小球肾炎(SGn)的患者。单因素和多因素logistic回归分析用于预测SGn。& # x0D;结果:432例患者纳入研究。其中57.9%患有PGn。风湿病、恶性肿瘤和感染是最常见的SGn病因,占近75%。单因素分析显示,α -1 (α1)、γ (Ɣ)和白蛋白含量在PGn组和SGn组之间存在显著差异。ROC曲线分析确定(α1*Ɣ)/白蛋白比值的临界值为1.48。多因素分析显示,血清总蛋白和(α1*Ɣ)/白蛋白比值是SGn的独立预测因子(p=0.020, p= 0.05)
{"title":"An underestimated old friend: Serum protein electrophoresis in the differential diagnosis of glomerulopathies","authors":"Ahmet Bilgehan ŞAHİN, Safiye BAKKAL, Saide GÜLLÜLÜ, Ayşegül ORUÇ, Abdülmecit YILDIZ, Mehmet Fethullah AYDIN, Alparslan ERSOY, Gökhan OCAKOĞLU, Mustafa GÜLLÜLÜ","doi":"10.46310/tjim.1358169","DOIUrl":"https://doi.org/10.46310/tjim.1358169","url":null,"abstract":"Background: Serum protein electrophoresis (SPEP) is an easy test separating serum proteins based on their physical and chemical properties. Although it is frequently used in the differential diagnosis of multiple myeloma and various chronic inflammatory diseases, its value in the etiologic classification of glomerular diseases has yet to be studied.
 Material and Methods: We retrospectively reviewed the medical records of patients who underwent renal biopsy from 2008 to 2016 at our institution. We excluded patients who can not be classified as primary (PGn) or secondary glomerulonephritis (SGn). Univariate and multivariate logistic regression analyses were performed for the prediction of SGn. 
 Results: Four hundred thirty-two patients were included in the study. Of those, 57.9% had PGn. Rheumatological diseases, malignancies, and infections were the most common etiologic causes of SGn, accounting for nearly 75%. Univariate analysis revealed that alpha-1 (α1), gamma (Ɣ), and albumin fractions significantly differ between PGn and SGn groups. ROC curve analysis determined the cut-off value of (α1*Ɣ)/albumin ratio as 1.48. Multivariate analysis revealed that total serum protein and (α1*Ɣ)/albumin ratio were significantly independent predictors for SGn (p=0.020 and p","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"15 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contrast-Induced Acute Kidney Injury in Patients Followed at the Intensive Care Unit after Aneurysmal Subarachnoid Haemorrhage (Fisher Grade IV) Surgery:A Retrospective Study 动脉瘤性蛛网膜下腔出血(Fisher IV级)手术后重症监护病房患者造影剂诱导的急性肾损伤:回顾性研究
Pub Date : 2023-10-29 DOI: 10.46310/tjim.1358676
Hamide Ayben KORKMAZ, Rıfat AKDAĞ, İlkay CEYLAN
Background: Contrast-enhanced imaging studies are widely used to diagnose and follow up acute cerebrovascular diseases. Exposure to contrast media may lead to nephropathy. This study investigated the incidence of contrast-induced acute kidney injury during intensive care follow-up of patients who underwent aneurysmal subarachnoid haemorrhage surgery and the impact of this condition on patient outcomes. Material and Methods: Patients >18 years of age with no known renal injury and admitted to the intensive care unit after Fisher Grade IV aneurysmal subarachnoid haemorrhage and surgery between January 2017 and June 2022 were retrospectively analysed. Renal injury was defined as a renal injury occurring within 48 hours of exposure to contrast media in line with the Kidney Disease Improving Global Outcomes criteria. Results: Among the 85 patients with subarachnoid haemorrhage who received at least one contrast medium, the mean age was 55, and 40% were female. 11.8% of the patients were found to have early acute kidney injury and were non-oliguric. At 48 hours, six, three, and one patients had Stage 1, 2, and 3 injuries, respectively. None of the patients required renal replacement therapy. Patients received a mean of 2 mL/kg/h saline infusion after contrast media administration and had a mean arterial pressure of 93.6 mmHg. There was no association between acute kidney injury and comorbidities, Glasgow coma scale, or APACHE II scores. Conclusions: The study found that the incidence of contrast-induced acute kidney injury was low and transient in patients followed at the ICU after aneurysmal subarachnoid haemorrhage (Fisher Grade IV) surgery. Adequate hydration and hemodynamic stability were found to be effective in reducing acute kidney injury in these patients.
背景:对比增强成像在急性脑血管疾病的诊断和随访中应用广泛。接触造影剂可能导致肾病。本研究探讨动脉瘤性蛛网膜下腔出血手术患者重症监护随访期间造影剂所致急性肾损伤的发生率及其对患者预后的影响。 材料和方法:回顾性分析2017年1月至2022年6月期间因Fisher IV级动脉瘤性蛛网膜下腔出血和手术而入住重症监护病房的18岁无已知肾损伤患者。根据肾脏疾病改善全球结局标准,肾损伤定义为暴露于造影剂48小时内发生的肾损伤。 结果:85例蛛网膜下腔出血患者接受至少一种造影剂治疗,平均年龄55岁,女性占40%。11.8%的患者发现有早期急性肾损伤和非少尿。48小时时,分别有6名、3名和1名患者出现1期、2期和3期损伤。没有患者需要肾脏替代治疗。造影剂给药后,患者平均接受2 mL/kg/h生理盐水输注,平均动脉压为93.6 mmHg。急性肾损伤与合并症、格拉斯哥昏迷评分或APACHE II评分没有关联。 结论:本研究发现,动脉瘤性蛛网膜下腔出血(Fisher IV级)术后在ICU随访的患者中,造影剂引起的急性肾损伤发生率较低且为短暂性。充分的水合作用和血流动力学稳定性对减轻这些患者的急性肾损伤是有效的。
{"title":"Contrast-Induced Acute Kidney Injury in Patients Followed at the Intensive Care Unit after Aneurysmal Subarachnoid Haemorrhage (Fisher Grade IV) Surgery:A Retrospective Study","authors":"Hamide Ayben KORKMAZ, Rıfat AKDAĞ, İlkay CEYLAN","doi":"10.46310/tjim.1358676","DOIUrl":"https://doi.org/10.46310/tjim.1358676","url":null,"abstract":"Background: Contrast-enhanced imaging studies are widely used to diagnose and follow up acute cerebrovascular diseases. Exposure to contrast media may lead to nephropathy. This study investigated the incidence of contrast-induced acute kidney injury during intensive care follow-up of patients who underwent aneurysmal subarachnoid haemorrhage surgery and the impact of this condition on patient outcomes.
 Material and Methods: Patients >18 years of age with no known renal injury and admitted to the intensive care unit after Fisher Grade IV aneurysmal subarachnoid haemorrhage and surgery between January 2017 and June 2022 were retrospectively analysed. Renal injury was defined as a renal injury occurring within 48 hours of exposure to contrast media in line with the Kidney Disease Improving Global Outcomes criteria.
 Results: Among the 85 patients with subarachnoid haemorrhage who received at least one contrast medium, the mean age was 55, and 40% were female. 11.8% of the patients were found to have early acute kidney injury and were non-oliguric. At 48 hours, six, three, and one patients had Stage 1, 2, and 3 injuries, respectively. None of the patients required renal replacement therapy. Patients received a mean of 2 mL/kg/h saline infusion after contrast media administration and had a mean arterial pressure of 93.6 mmHg. There was no association between acute kidney injury and comorbidities, Glasgow coma scale, or APACHE II scores.
 Conclusions: The study found that the incidence of contrast-induced acute kidney injury was low and transient in patients followed at the ICU after aneurysmal subarachnoid haemorrhage (Fisher Grade IV) surgery. Adequate hydration and hemodynamic stability were found to be effective in reducing acute kidney injury in these patients.","PeriodicalId":23372,"journal":{"name":"Turkish Journal of Internal Medicine","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136133551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turkish Journal of Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1